Literature DB >> 24271521

Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats.

M W Teunissen1, I O Brorens, H J De Langen, A M Geerlings, D D Breimer.   

Abstract

Two model substrates for oxidative hepatic enzyme activity, viz. antipyrine (A) and theophylline (T), were given simultaneously to rats by iv administration. Blood concentrations of A and T were measured by a high-performance liquid chromatographic (HPLC) method. Urinary excretions of A, T, and the major metabolites arising from A-4-hydroxyantipyrine (OHA), norantipyrine (NORA), 3-hydroxymethylantipyrine (HMA), and 4,4'-dihydroxyantipyrine (DOHA)-and from T-1-methyluric acid (1-MU) and 1,3-dimethyluric acid (1,3-DMU)-were also determined by HPLC. It was found that the pharmacokinetic parameters obtained after the simultaneous administration of A and T at relatively low dose levels (A, 5.0 mg; and T, 1.3 mg) were not different from those obtained after the separate administration of A or T at the same dose level. In order to investigate whether the metabolic pathways of A and T are mediated by the same or closely related forms of the cytochrome P-450 system, metabolic clearances of A (CLA,M) and T (CLT,M) and the clearances for production of their various metabolites, obtained in untreated rats and in rats pretreated with 3-methylcholanthrene (MC) or with MC followed by 9-hydroxyellipticine (E), were correlated. These two compounds are a selective cytochrome P-448 inducer and inhibitor, respectively. Strong correlations were found between CLT,M and the clearances for production of OHA, NORA, and DOHA but not HMA. The best correlation, however, was observed between CLT,M and CLOHA, not only when all data points were taken into account (r = 0.99), but also in separate pretreatment groups (r ranging from 0.87 to 0.92). Moreover, the slopes of these correlation lines varied only slightly among groups, while the intercepts were not significantly different from zero. In the separate pretreatment groups, the correlation coefficients for the correlations between CLT,M and the clearance for production of the other metabolites of A were considerably lower, while the slopes of the correlation lines varied substantially. Clearances for production of the metabolites of T were strongly correlated with each other (r = 0.99) and with CLOHA (r = 0.95). It can be concluded that theophylline metabolism and formation of OHA are mediated by the same or very similar forms of cytochrome P-450, whereas formation of the other major metabolites of A is not or only partly. The study of the various pathways of metabolism after simultaneous administration of drugs is a powerful tool in the study of correlations in drug metabolism in vivo.

Entities:  

Year:  1986        PMID: 24271521     DOI: 10.1023/A:1016361907787

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Effects of phenobarbital and 3-methylcholanthrene pretreatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats.

Authors:  J F Williams; S Lowitt; A Szentivanyi
Journal:  Biochem Pharmacol       Date:  1979-10-01       Impact factor: 5.858

2.  Interindividual variations in drug disposition. Clinical implications and methods of investigation.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

3.  Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.

Authors:  M W Teunissen; R P Joeres; N P Vermeulen; D D Breimer
Journal:  Xenobiotica       Date:  1983-04       Impact factor: 1.908

4.  Dose-dependent elimination of theophylline in rats.

Authors:  M W Teunissen; I O Brorens; J M Geerlings; D D Breimer
Journal:  Xenobiotica       Date:  1985-02       Impact factor: 1.908

5.  Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1982-01       Impact factor: 4.030

6.  Interindividual differences in drug oxidation: clinical importance.

Authors:  F Sjöqvist; C von Bahr
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

7.  Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.

Authors:  M Danhof; D P Krom; D D Breimer
Journal:  Xenobiotica       Date:  1979-11       Impact factor: 1.908

8.  Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.

Authors:  M W Teunissen; M Van Graft; N P Vermeulen; D D Breimer
Journal:  Xenobiotica       Date:  1983-08       Impact factor: 1.908

9.  Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.

Authors:  M van der Graaff; N P Vermeulen; R P Joeres; T Vlietstra; D D Breimer
Journal:  J Pharmacol Exp Ther       Date:  1983-11       Impact factor: 4.030

10.  Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children.

Authors:  E Sarrazin; L Hendeles; M Weinberger; K Muir; S Riegelman
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.